Sabin Begins Marburg Vaccine Trial in U.S.
On Apr. 16, 2025, The Sabin Vaccine Institute announces the launch of a multi-site Phase 2 clinical trial…
Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
Australia’s first durable total artificial heart implant Reported successful
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
University of Queensland team finds relative of deadly Hendra virus in the U.S.
On Jan. 29, 2025, researchers at The University of Queensland announced they have identified the first henipavirus in…
University of Queensland manufactures 3D printed scaffolding to rebuild jaw bones
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…
Drug-resistant hookworms put pets and people at risk
On Jan. 7, 2025, scientists at The University of Queensland (UQ) and the University of Sydney announced they…
Study finds fluoride in water does not affect brain development
On Dec. 19, 2024, a University of Queensland (UQ) study has found no link between exposure to water…
Biotechnology | Disease | Life Science News | Medical Device | Non-Profit Research | Organ Transplant | Therapeutics
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Neurology | Therapeutics
University of Queensland ultrasound treatment for Alzheimer’s licensed to new startup
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
Risk of depression and heart disease linked in women
On Dec. 5, 2024, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
World-first cure for lethal skin disease achieved in landmark study
On Nov. 11, 2024, an international team of researchers has for the first time cured patients with Toxic…
De-extinction company claimed it has nearly complete Tasmanian tiger Genome
On Oct. 17, 2024, Colossal Biosciences, an American biotechnology and genetic engineering company, announced that it has a…
CSIRO scientists Sequenced first full genome of critically endangered ‘Walking’ Australian Spotted handfish
On Oct. 8, 2024, scientists from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency,…
Biotechnology | Disease | Life Science News | Medical Device | Non-Profit Research | Organ Transplant | Therapeutics
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
World Health Organization confirmed case of human infection with avian influenza A(H5N1) virus in Australia
On May 22, 2024, the World Health Organization (WHO) announced that the first confirmed case of human infection…
Hugel Received FDA Approval in the U.S. of Letybo (letibotulinumtoxinA-wlbg) for Injection for Treatment of Glabellar Lines
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
Australian government approved release of QUT-developed GM Cavendish QCAV-4
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
BioNTech and Australiaﾒs State of Victoria signed agreement on strategic partnership to strengthen mRNA rcosystem
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Neurology | NIH | Vaccine
Influenza viruses may have originated in fish 600 million years ago
On Feb. 28, 2023, a team from the University of Sydney reported that a flu virus found in…
Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
Novavax Nuvaxovid COVID-19 vaccine recommended by CHMP for expanded conditional Marketing Authorization in EU as booster for adults
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
Oldest clinical case of Klinefelter Syndrome was detected in a 1,000-year-old Portuguese skeleton
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…
Novavax Nuvaxovid COVID-19 vaccine granted provisional registration in Australia for use in adolescents aged 12 through 17
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…
Australia TGA granted provisional approval for Moderna’s COVID-19 vaccine in children aged six months to five years
On Jul. 18, 2022, Moderna announced that the Therapeutic Goods Administration (TGA) in Australia had granted provisional registration…
Novavax COVID-19 vaccine Nuvaxovid provisionally registered in Australia as booster in individuals aged 18 and over
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
Multi-country outbreak reported in Twelve member nations not endemic for Mpox Virus
On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…
Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great Britain
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
Moderna finalized strategic partnership with Australian government
On Mar. 23, 2022, Moderna announced the finalization of a strategic partnership with the Australian Federal Government to…
Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)
On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…